Melatonin and Sertraline

Supplement–drug interaction evidence from the TruthStack database.

SeverityHIGH
Evidence TierModerate
Interaction TypeSEROTONERGIC RISK
MechanismPHARMACODYNAMIC
Last Reviewed2026-02-24
Source Verification
Attestation METHODOLOGY_ATTESTED
Corpus manifest 26b2d684...
Last reviewed 2026-02-24
Primary source 25503107
Live attestation Query API — returns signed DAA ID per request
Data license CC BY 4.0

Summary

Melatonin is metabolized by CYP1A2 and has serotonergic properties. SSRIs may inhibit CYP1A2, increasing melatonin levels. Additive serotonergic effects theoretically possible. FAERS: 2,390 reports. Generally lower risk than other serotonergic combinations but monitor for excessive sedation.

API Reference

GET https://api.truthstack.co/v1/check?c1=melatonin&c2=sertraline

Open, unauthenticated. Returns JSON. Developer documentation

Sources

Primary: 25503107

Related Interactions

What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.